Recherchez et trouvez le CMO / CDMO dont vous avez besoin
Discover highly skilled partners for your drug development and manufacturing project.
Italie
Adare Pharma | US
Adare Pharma Solutions
Adare Pharma es un CDMO global con instalaciones en EE.UU. y la UE, que ofrece desarrollo de productos llave en mano mediante experiencia en fabricación comerci
MARCHÉS: DIGEMID (Peru), ANMAT (Argentina), EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAILLE DU LOT: Petit, Moyen, Grandes dimensions
CATÉGORIE / PRODUIT: FDF / PRODUITS PHARMACEUTIQUES, SERVICES, CHIMIQUE-SYNTHÉTIQUE
COMPLIANCE: EMA (BPF DE L'UE), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), Organisation mondiale de la santé (BPF / HACCP), MHRA (BPF AU ROYAUME-UNI), Service public français (CIR), TGA (Australia GMP), FDA (cGMP), NMPA (BPF de Chine), ECOVADIS, ISO, Conseil de recherche sur le halal, Santé Canada (Canada GMP), TITCK (Turkish Health Authorities), MFDS/KFDA (République de Corée GMP)
RÉGION: Europe, North America
USAGE: Humain, Vétérinaire
SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (bandes d´exposition professionnelle): 2 (PDE = 1 000 - 5 000 µg/jour), 4 / HPAPI (PDE = 10 - 100 µg/jour), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1 000 µg/jour)
DOMAINES THÉRAPEUTIQUES D´EXPERTISE (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals
Italie
Adare Pharma | EU
Adare Pharma Solutions
Global CDMO offering turnkey product development through commercial manufacturing expertise, focused on oral dosage forms.
MARCHÉS: DIGEMID (Peru), ANMAT (Argentina), EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAILLE DU LOT: Petit, Moyen, Grandes dimensions
DOMAINES THÉRAPEUTIQUES D´EXPERTISE (ATC): (R) Respiratory system, (V01) Allergens, (M) Musculoskeletal system, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system
CATÉGORIE / PRODUIT: FDF / PRODUITS PHARMACEUTIQUES, SERVICES, INGÉNIERIE DES PARTICULES, CHIMIQUE-SYNTHÉTIQUE
COMPLIANCE: EMA (BPF DE L'UE), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), Organisation mondiale de la santé (BPF / HACCP), MHRA (BPF AU ROYAUME-UNI), Service public français (CIR), TGA (Australia GMP), FDA (cGMP), NMPA (BPF de Chine), ECOVADIS, ISO, Conseil de recherche sur le halal, Santé Canada (Canada GMP), TITCK (Turkish Health Authorities), MFDS/KFDA (République de Corée GMP)
RÉGION: Europe
USAGE: Humain, Vétérinaire
SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (bandes d´exposition professionnelle): 2 (PDE = 1 000 - 5 000 µg/jour), 4 / HPAPI (PDE = 10 - 100 µg/jour), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1 000 µg/jour)
Allemagne
Aenova Group - Location Cornu, Romania
Aenova
Centro de competencia y ventanilla única para cápsulas de gelatina blanda y VegaGels.
TAILLE DU LOT: Petit, Moyen, Grandes dimensions
CATÉGORIE / PRODUIT: FDF / PRODUITS PHARMACEUTIQUES, NUTRACEUTICALS, CHIMIQUE-SYNTHÉTIQUE
COMPLIANCE: EMA (BPF DE L'UE), TGA (Australia GMP), FDA (cGMP), ISO, Conseil de recherche sur le halal, Santé Canada (Canada GMP)
RÉGION: Europe
USAGE: Humain
SERVICES: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services
OEB (bandes d´exposition professionnelle): 2 (PDE = 1 000 - 5 000 µg/jour), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1 000 µg/jour)
MARCHÉS: FDA (USA), TGA (Australia), Health Canada (Canada)
Limited view
FDF / PRODUITS PHARMACEUTIQUES manufacturing site
MAI network supplier
Demo facility
Location available after registration
Limited view
FDF / PRODUITS PHARMACEUTIQUES manufacturing site
MAI network supplier
CDMO EXPERTA E INNOVADORA EN SÓLIDOS ORALES COMPLEJOS: CDMO francesa totalmente integrada Skyepharma es un actor clave en el desarrollo de fármacos y la administración de tecnologías orales al…
Location available after registration
Limited view
FDF / PRODUITS PHARMACEUTIQUES manufacturing site
MAI network supplier
Desarrollador y fabricante de nuevos medicamentos con tecnologías de liberación controlada.
Location available after registration
More facilities on the network
Register to unlock the full catalog with contact details and locations.
+1 more facilities
Create free account